Skip to content

Evaluating effective management of snoring in type 2 diabetic patients through homoeopathy.

To Evaluate the Effectiveness of Individualized Homeopathic Medicines vs. Placebo in the Management of Obstructive Sleep Apnea in Patients with Type 2 Diabetes Mellitus Undergoing Conventional Treatment. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094147
Enrollment
30
Registered
2025-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E089- Diabetes mellitus due to underlying condition without complications

Interventions

Intervention1: Individualized Homeopathic Medicines: After case taking and analysis individualized homeopathic medicine will be given for two weeks and followed up thereafter six months Duration Six

Sponsors

Dr Neeraj Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having Clinical signs and symptoms suggestive of Obstructive Sleep Apnea OSA such as loud snoring observed apneas or excessive daytime sleepiness in diagnosed cases of Type 2 DM under conventional treatment Patients Clinically diagnosed with obstructive sleep apnea as confirmed by an Apnea Hypopnea Index within the range indicative of mild to moderate OSA Patients of age group 30 years to 70 years Both male and female patients will be included Overweight and obese individuals defined as having a Body Mass Index of 25kg per meter square or above indicating increased risk of OSA

Exclusion criteria

Exclusion criteria: TYPE 2 DM Patients suffering from any life-threatening illness and its complications. Individuals with Type 2 Diabetes Mellitus currently undergoing insulin therapy. Use of continuous positive airway pressure (CPAP) therapy. Patients who are terminally ill, under immunosuppressive treatment. Patients of malignancy Extremely sick patients Any known heart conditions, CHF, MI etc. Serious mental illness & seizure disorder. Patients unable to comply with the study protocol (including psychiatric diseases). Lactating mothers and pregnant ladies are excluded. Patients having major airway obstruction needing surgical intervention. Patient not willing to give consent for participating in this study.

Design outcomes

Primary

MeasureTime frame
Polysomnography findingTimepoint: 1st will be done at the baseline 2nd will be done at third month 3rd will be done at sixth month

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index Sleep Apnea Quality of Life Index Epworth Sleepiness Scale Improvement in diabetic symptoms & glycemic control Timepoint: 1st will be done at the baseline 2nd will be done at third month 3rd will be done at sixth month

Countries

India

Contacts

Public ContactDr Neeraj Gupta

SHMC and Hosp

drneerajgupta2003@yahoo.co.in09212013664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026